IMMUNOTOXICITY

IMMUNOTOXICITY was reported 114 times

IMMUNOTOXICITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Ligand-1 Blocker [EPC] 22 0.0010
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 77 0.0008
2 CTLA-4-directed Blocking Antibody [EPC] 14 0.0003
3 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 2 0.0002
4 Microtubule Inhibitor [EPC] 34 0.0002
5 Platinum-based Drug [EPC] 43 0.0002
6 Stimulant Laxative [EPC] 2 0.0001
7 Nitrofuran Antibacterial [EPC] 2 0.0001
8 Serotonin-3 Receptor Antagonist [EPC] 11 0.0001
9 Topoisomerase Inhibitor [EPC] 3 0.0000
10 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 4 0.0000
11 Vascular Endothelial Growth Factor Inhibitor [EPC] 6 0.0000
12 Vitamin B12 [EPC] 8 0.0000
13 HMG-CoA Reductase Inhibitor [EPC] 9 0.0000
14 Fluoroquinolone Antibacterial [EPC] 3 0.0000
15 Proton Pump Inhibitor [EPC] 13 0.0000
16 Opioid Agonist [EPC] 6 0.0000
17 Folate Analog Metabolic Inhibitor [EPC] 9 0.0000
18 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
19 Atypical Antipsychotic [EPC] 9 0.0000
20 Benzodiazepine [EPC] 13 0.0000
21 Osmotic Laxative [EPC] 5 0.0000
22 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
23 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
24 Aldosterone Antagonist [EPC] 2 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 13 0.0000
27 Corticosteroid [EPC] 12 0.0000
28 alpha-Adrenergic Blocker [EPC] 1 0.0000
29 Leukocyte Growth Factor [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 4 0.0000
31 Insulin Analog [EPC] 3 0.0000
32 Vitamin D [EPC] 2 0.0000
33 Kinase Inhibitor [EPC] 3 0.0000
34 Vitamin C [EPC] 2 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
36 Thalidomide Analog [EPC] 2 0.0000
37 beta-Adrenergic Blocker [EPC] 1 0.0000
38 Loop Diuretic [EPC] 1 0.0000